Unleashing the immune system to fight tumors—an approach enabled by immunotherapy—has led to remarkable outcomes in some cancer patients, but in many more, cancer cells evade the treatment and continue to spread. Now, ...
Nov 2, 2018
0
64
The development of immunotherapy, which mobilizes the body's own immune system to destroy cancer cells, is one of the greatest advances in cancer treatment, but immunotherapy can cause harm to healthy tissue in some patients. ...
Oct 31, 2018
0
35
Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this nanofluidic seed makes it possible to deliver ...
Oct 23, 2018
0
603
Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.
Oct 22, 2018
0
0
There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer.
Oct 21, 2018
1
2940
Wistar scientists and collaborators demonstrate for the first time that through engineering constructs, they can express DNA-encoded monoclonal antibodies (DMAbs) targeting CTLA-4, an important cancer checkpoint molecule ...
Oct 4, 2018
0
33
Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types ...
Sep 27, 2018
0
4
Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment, according to research published today (Wednesday) in the Journal of Experimental ...
Sep 26, 2018
0
1
Researchers have developed a simple blood test that can select cancer patients where therapies that use the body's own immune system (immunotherapies) are more likely to be effective.
Sep 6, 2018
0
0
A group of men with especially aggressive prostate cancer may respond unusually well to immunotherapy, a major new study reports.
Sep 5, 2018
0
12
